AIM:DESTAIM:DESTBiotechsFor Destiny Pharma plc (LON:DEST) insiders, selling UK£420k worth of stock earlier this year was a smart move.May 17, 2022Last week, Destiny Pharma plc's (LON:DEST) stock jumped 15%, but insiders who sold UK£420k worth of stock in over the...
AIM:CIRAIM:CIRBiotechsCircassia Group (LON:CIR) adds UK£20m to market cap in the past 7 days, though investors from five years ago are still down 63%May 17, 2022This week we saw the Circassia Group Plc ( LON:CIR ) share price climb by 15%. But that doesn't change the fact that...
LSE:GNSLSE:GNSBiotechsDoes The Market Have A Low Tolerance For Genus plc's (LON:GNS) Mixed Fundamentals?May 14, 2022Genus (LON:GNS) has had a rough three months with its share price down 27%. We, however decided to study the company's...
LSE:OXBLSE:OXBBiotechsInvestors Shouldn't Be Too Comfortable With Oxford Biomedica's (LON:OXB) Robust EarningsMay 02, 2022Oxford Biomedica plc's ( LON:OXB ) robust earnings report didn't manage to move the market for its stock. Our analysis...
AIM:ABCAIM:ABCBiotechsIs Abcam (LON:ABC) A Risky Investment?May 01, 2022Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
LSE:PRTCLSE:PRTCBiotechsIs PureTech Health (LON:PRTC) A Risky Investment?April 28, 2022David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
AIM:AVCTAIM:AVCTBiotechsThe 12% return this week takes Avacta Group's (LON:AVCT) shareholders three-year gains to 338%April 25, 2022For us, stock picking is in large part the hunt for the truly magnificent stocks. Not every pick can be a winner, but...
AIM:ETXAIM:ETXBiotechsInsiders who purchased e-therapeutics plc (LON:ETX) earlier this year lose an additional UK£35k as the stock sinks to UK£0.24April 25, 2022The recent price decline of 11% in e-therapeutics plc's ( LON:ETX ) stock may have disappointed insiders who bought...
LSE:OXBLSE:OXBBiotechsOxford Biomedica plc (LON:OXB) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?April 22, 2022With its stock down 38% over the past three months, it is easy to disregard Oxford Biomedica (LON:OXB). However, stock...